Icecure Medical Ltd (NASDAQ:ICCM) shares, rose in value on Friday, July 11, with the stock price up by 2.97% to the previous day’s close as strong demand from buyers drove the stock to $1.04.
Actively observing the price movement in the last trading, the stock closed the session at $1.01, falling within a range of $1.01 and $1.05. The value of beta (5-year monthly) was 2.594. Referring to stock’s 52-week performance, its high was $1.63, and the low was $0.47. On the whole, ICCM has fluctuated by 2.41% over the past month.
With the market capitalization of Icecure Medical Ltd currently standing at about $71.44 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-28.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ICCM’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of ICCM currently trading nearly 5.19% and 2.58% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 53.38, while the 7-day volatility ratio is showing 7.64% which for the 30-day chart, stands at 7.33%. Furthermore, Icecure Medical Ltd (ICCM)’s beta value is 1.40.
A comparison of Icecure Medical Ltd (ICCM) with its peers suggests the former has fared considerably weaker in the market. ICCM showed an intraday change of 2.97% in last session, and over the past year, it shrunk by -3.64%%.
Data on historical trading for Icecure Medical Ltd (NASDAQ:ICCM) indicates that the trading volumes over the past 10 days have averaged 0.37 and over the past 3 months, they’ve averaged 270.80K. According to company’s latest data on outstanding shares, there are 58.62 million shares outstanding.
Nearly 49.23% of Icecure Medical Ltd’s shares belong to company insiders and institutional investors own 0.23% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.21 million shares as on 2025-06-13, resulting in a short ratio of 0.93. According to the data, the short interest in Icecure Medical Ltd (ICCM) stood at 414.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 0.23 million. The stock has risen by 43.23% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ICCM stock heading into the next quarter.
